Curis
CRIS
#10186
Rank
A$18.68 M
Marketcap
A$1.36
Share price
-5.93%
Change (1 day)
-69.88%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.26. In 2024 the company made an earnings per share (EPS) of A-$10.07 an increase over its 2023 EPS that were of A-$12.93.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-42.51%
2024A-$10.07-22.15%
2023A-$12.93-26.17%
2022A-$17.5122.3%
2021A-$14.32-25.37%
2020A-$19.19-30.93%
2019A-$27.78-2.02%
2018A-$28.35
2016A-$64.44-10%
2015A-$71.60138.1%
2014A-$30.0740%
2013A-$21.48-25%
2012A-$28.6466.67%
2011A-$17.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.95-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.25-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$3.41-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$4.84-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.10 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.02-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA